Translocator protein (18 kDa) TSPO: An emerging therapeutic target in neurotrauma

Abstract

Traumatic brain injury (TBI) induces physical, cognitive, and psychosocial deficits that affect millions of patients. TBI activates numerous cellular mechanisms and molecular cascades that produce detrimental outcomes, including neuronal death and loss of function. The mitochondrion is one of the major targets of TBI, as seen by increased mitochondrial activity in activated and proliferating microglia (due to high energy requirements and/or calcium overload) as well as increased reactive oxygen species, changes in mitochondrial permeability transition, release of cytochrome c, caspase activation, reduced ATP levels, and cell death in neurons. Translocator protein (TSPO) is an 18-kDa outer mitochondrial membrane protein that interacts with the mitochondria permeability transition pore and binds with high affinity to cholesterol and various classes of drug ligands, including some benzodiazepines such as 4′-chlorodiazepam (Ro5-4864). Although TSPO levels in the brain are low, they are increased after brain injury and inflammation. This finding has led to the proposed use of TSPO expression as a marker of brain injury and repair. TSPO drug ligands have been shown to participate in the control of mitochondrial respiration and function, mitochondrial steroid and neurosteroid formation, as well as apoptosis. This review and commentary will outline our current knowledge of the benefits of targeting TSPO for TBI treatment and the mechanisms underlying the neuroprotective effects of TSPO drug ligands in neurotrauma.

Assessment of Neuroinflammation in Transferred EAE Via a Translocator Protein Ligand

“…These results confirm the reliability of the translocator protein (Papadopoulos & Lecanu, 2009) in early diagnostics of antigen-specific neuroinflammation and eventuallyof MS.…”

Neuroinflammation in Schizophrenia-Related Psychosis: A PET Study

“…It cannot, however, be ruled out that treatment with benzodiazepines affected the expression of the PBR. Most studies on benzodiazepines and other PBR ligands, such as Ro5-4864 and PK11195, indicate the neuroprotective effects of these ligands (35). Wilms et al (36) have shown that midazolam, clonazepam, and diazepam interfered with the in vitro synthesis and release of proinflammatory cytokines by microglia cells.…”

El cáncer bucal y su relación con la proteína translocadora mitocondrial de 18kda

“…Esta se localiza a nivel de las membranas mitocondriales de distintos tipos celulares (25). El nombre de TSPO fue adoptado en el 2006 debido a nuevos hallazgos relacionados con su estructura y función molecular (24).…”